Naloxone; possession and administration, employee or person acting on behalf of a public place. (HB908)

Introduced By

Del. Cliff Hayes (D-Chesapeake) with support from co-patron Del. Wendy Gooditis (D-Clarke)

Progress

Introduced
Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law

Description

Naloxone; possession and administration; employee or person acting on behalf of a public place. Authorizes an employee or other person acting on behalf of a public place, as defined in the bill, who has completed a training program on the administration of naloxone or other opioid antagonist to possess and administer naloxone or other opioid antagonist, other than naloxone in an injectable formulation with a hypodermic needle or syringe, in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health. The bill also provides that a person who is not otherwise authorized to administer naloxone or other opioid antagonist used for overdose reversal may administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose. The bill provides immunity from civil liability for a person who, in good faith, administers naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose, unless such act or omission was the result of gross negligence or willful and wanton misconduct. This bill incorporates HB 650, HB 1465, and HB 1466. Read the Bill »

Outcome

Bill Has Passed

History

DateAction
01/07/2020Committee
01/07/2020Prefiled and ordered printed; offered 01/08/20 20104833D
01/07/2020Referred to Committee on Health, Welfare and Institutions
01/16/2020Impact statement from DPB (HB908)
01/20/2020Assigned HWI sub: Health Professions
01/30/2020Subcommittee recommends reporting with substitute (6-Y 0-N)
02/04/2020Committee substitute printed 20107306D-H1
02/04/2020Incorporates HB 1465 (Gooditis)
02/04/2020Incorporates HB1466 (Gooditis)
02/04/2020Incorporates HB650 (Hope)
02/04/2020Reported from Health, Welfare and Institutions with substitute (22-Y 0-N) (see vote tally)
02/05/2020Read first time
02/06/2020Read second time
02/06/2020Committee substitute agreed to 20107306D-H1
02/06/2020Engrossed by House - committee substitute HB908H1
02/07/2020Read third time and passed House BLOCK VOTE (100-Y 0-N)
02/07/2020VOTE: Block Vote Passage (100-Y 0-N) (see vote tally)
02/10/2020Impact statement from DPB (HB908H1)
02/10/2020Constitutional reading dispensed
02/10/2020Referred to Committee on Education and Health
02/27/2020Reported from Education and Health (14-Y 0-N) (see vote tally)
02/28/2020Constitutional reading dispensed (37-Y 0-N) (see vote tally)
03/02/2020Read third time
03/02/2020Passed Senate (40-Y 0-N) (see vote tally)
03/05/2020Enrolled
03/05/2020Bill text as passed House and Senate (HB908ER)
03/05/2020Impact statement from DPB (HB908ER)
03/06/2020Signed by Speaker
03/06/2020Signed by President
03/12/2020Enrolled Bill communicated to Governor on March 12, 2020
03/12/2020G Governor's Action Deadline 11:59 p.m., April 11, 2020
04/09/2020G Approved by Governor-Chapter 924 (effective 7/1/20)
04/09/2020G Acts of Assembly Chapter text (CHAP0924)